VIGL

VIGL

USD

Vigil Neuroscience Inc. Common Stock

$1.820+0.033 (1.830%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$1.787

Máximo

$1.870

Mínimo

$1.770

Volumen

0.01M

Fundamentos de la Empresa

Capitalización de Mercado

84.9M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.24M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $1.312Actual $1.820Máximo $6.06

Noticias Relacionadas

Analyst Upgrades

Wedbush Maintains Outperform on Vigil Neuroscience, Lowers Price Target to $13

Wedbush analyst Laura Chico maintains Vigil Neuroscience with a Outperform and lowers the price target from $24 to $13.

Ver más
Wedbush Maintains Outperform on Vigil Neuroscience, Lowers Price Target to $13
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Vigil Neuroscience, Lowers Price Target to $14

HC Wainwright & Co. analyst Andrew Fein maintains Vigil Neuroscience with a Buy and lowers the price target from $17 to $14.

Ver más
HC Wainwright & Co. Maintains Buy on Vigil Neuroscience, Lowers Price Target to $14
GlobeNewswire

Vigil Neuroscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Updates

– Announced positive data from Phase 1 clinical trial evaluating VG-3927 for potential treatment of Alzheimer's Disease (AD); plans to initiate Phase 2 clinical trial in Q3 2025 – – On track to report final analysis

Ver más
Vigil Neuroscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Updates

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.